A new market study, titled “Antiviral Drugs – Global Market Outlook (2016-2022)” has been featured on WiseGuyReports.
According to research report, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.
HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.
Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.
Applications Covered:
- Hepatitis-B antivirals
- Hepatitis-C antivirals
- Herpes virus
- HIV antivirals
- Influenza
- Other Applications
o Pneumonia
o Flu
Request Sample Report at https://www.wiseguyreports.com/sample-request/1184388-antiviral-drugs-global-market-outlook-2016-2022
End-Users Covered:
- Ambulatory Surgical Centers
- Clinics
- Hospitals
Distribution Channels covered:
- Hospital Pharmacy Store
- Online Pharmacy
- Retail Pharmacy Store
Product Types Covered:
- Generic Drugs
- Branded Drugs
Action Mechanisms covered:
- Nucleotide polymerase inhibitor
- Protease inhibitors
- Reverse transcriptase inhibitors
- Other Action Mechanisms
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Antiviral Drugs Market, By Application
6 Global Antiviral Drugs Market, By End-User
7 Global Antiviral Drugs Market, By Distribution Channels
8 Global Antiviral Drugs Market, By Product Type
9 Global Antiviral Drugs Market, By Action Mechanism
10 Global Antiviral Drugs Market, By Geography
11 Key Developments
12 Company Profiling
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)